ACTG Network Monthly Newsletter - August 2016

Date: 08/30/2016

Publication:

ACTG

Women's Outreach Workers Project Releases New Educational Video


New Video Addresses Questions Women and Minorities May Have Regarding ACTG Network Clinical Trials

The Women's Outreach Workers (WOW) Project was established with the goal of developing optimal strategies for increasing recruitment and retention of women, particularly women of color in ACTG Network clinical trials. Led by Susan E. Cohn, MD, MPH, Investigator at our Northwestern University Site, and working in collaboration with the Women's Health Inter-Network Scientific Committee (WHISC) and the Underrepresented Populations Committee (UPC), the WOW Project team created an educational video to help to answer many questions women and minorities may have about participating in ACTG Network clinical trials.


Click HERE for the rest of the article and to view the video.

Clinical Trials

NWCS 445: Novel Biomarkers to Shorten TB Treatment

Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...

Read More

P2026: Pharmacokinetic Properties of Antiretroviral and...

IMPAACT P1026s, the predecessor of this study, was first approved in 2003. P1026s enrolled over 1000 pregnant/postpartum women,...

Read More

A5288: MULTIOCTAVE, Management Using the Latest Technologies...

The study is being done to: test a strategy of using a resistance test to choose anti-HIV drugs. Resistance tests look at the...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

P1078: A Phase IV Randomized Double-Blind Placebo-Controlled...

P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...

Read More